Collegium to Host Conference Call to Discuss 2015 Financial Results and Provide Corporate Update
Conference Call Information:
To access the conference call, please dial (866) 864-3220 (U.S.) or (704) 908-0478 (International). An audio webcast will be accessible from the Investor Relations section of the Company’s website: http://www.collegiumpharma.com/. An archived webcast will be available on the Company’s website approximately two hours after the event.
About
Collegium is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patent-protected DETERx® technology platform for the treatment of chronic pain and other diseases. The DETERx oral drug delivery technology is designed to provide extended-release delivery, unique abuse-deterrent properties, and flexible dose administration options.
Contact:Douglas Carlson Vice President, Corporate Development dcarlson@collegiumpharma.com